IBT to increase cash-out

Shareholders agreed that International Biotechnology Trust (LSE:IBT) should return more cash to shareholders at last Friday's extraordinary general meeting, held at the demand of IBT's 10.06 percent shareholder, Millennium Partners (see BioCentury Extra, Friday July 7). Initially, the IBT board said it would return 45 million ($67.5 million) to shareholders. This was increased to up to 120 million just prior to the vote. IBT has now told BioCentury that this could increase further, although no figure has been set. ...